Small Intestine Cancer Recurrence
Small intestine cancer recurrence is often on the mind of a patient who has undergone treatment. Recurrent cancer is cancer that has come back after a patient has completed treatment and experienced a period of remission. The cancer may reappear after any length of time in the small intestine or in previously unaffected tissues or organs. A cancer is named for the place where it originated, so if it appears later in a different part of the body, it is still referred to as small intestine cancer.
It is important for a small intestine cancer patient to be vigilant regarding his or her health, paying close attention to potential symptoms of recurrent small intestine cancer. Follow-up appointments with a physician are also critical. During these visits, a physician may ask about any problems the patient is experiencing and might order lab and/or imaging tests to look for signs of small intestine cancer recurrence. Testing may include:
- A physical examination – A physician can check for physical signs of recurrence and address any symptoms a patient may be experiencing.
- Imaging tests – X-rays, CT scans, MRIs and other imaging tests can provide detailed pictures of a patient’s organs and tissues to help a physician spot abnormalities.
- Blood tests – A physician can look for certain substances in the blood, which, when elevated, could indicate that a tumor has formed.
Moffitt is the only cancer center based in Florida that has been designated a Comprehensive Cancer Center by the National Cancer Institute. We are continually working to develop innovative techniques to diagnose and treat small intestine cancer, and our robust clinical trials program is the source of groundbreaking therapies that are improving small intestine cancer survival rates and providing our patients with a higher quality of life.
For more information on small intestine cancer recurrence, contact Moffitt Cancer Center by calling 1-888-663-3488 or by filling out our new patient registration form. No referral is required.